These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 17724201)
1. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201 [TBL] [Abstract][Full Text] [Related]
2. Minimally activated CD8 autoreactive T cells specific for IRBP express a high level of Foxp3 and are functionally suppressive. Peng Y; Shao H; Ke Y; Zhang P; Han G; Kaplan HJ; Sun D Invest Ophthalmol Vis Sci; 2007 May; 48(5):2178-84. PubMed ID: 17460277 [TBL] [Abstract][Full Text] [Related]
3. In vitro activation of CD8 interphotoreceptor retinoid-binding protein-specific T cells requires not only antigenic stimulation but also exogenous growth factors. Peng Y; Shao H; Ke Y; Zhang P; Xiang J; Kaplan HJ; Sun D J Immunol; 2006 Apr; 176(8):5006-14. PubMed ID: 16585597 [TBL] [Abstract][Full Text] [Related]
4. [Effects of exogenous interleukin-2, interleukin-23 on differentiation of IRBP 1-20-specific T cells toward Th1 and Th17 and comparison of the pathogenicity of IRBP 1-20-specific T cells]. Li Y; Cui Y; Bi HS; Wang Y; Li J; Wang XR Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):224-9. PubMed ID: 23866703 [TBL] [Abstract][Full Text] [Related]
5. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis. Keino H; Watanabe T; Sato Y; Okada AA Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477 [TBL] [Abstract][Full Text] [Related]
6. Regulation of interphotoreceptor retinoid-binding protein (IRBP)-specific Th1 and Th17 cells in anterior chamber-associated immune deviation (ACAID). Cui Y; Shao H; Sun D; Kaplan HJ Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5811-7. PubMed ID: 19458338 [TBL] [Abstract][Full Text] [Related]
7. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6. Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802 [TBL] [Abstract][Full Text] [Related]
8. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells. Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946 [TBL] [Abstract][Full Text] [Related]
9. Suppression of established experimental autoimmune uveitis by anti-LFA-1alpha Ab. Ke Y; Sun D; Zhang P; Jiang G; Kaplan HJ; Shao H Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2667-75. PubMed ID: 17525198 [TBL] [Abstract][Full Text] [Related]
10. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice. Cortes LM; Mattapallil MJ; Silver PB; Donoso LA; Liou GI; Zhu W; Chan CC; Caspi RR Invest Ophthalmol Vis Sci; 2008 May; 49(5):1946-56. PubMed ID: 18436827 [TBL] [Abstract][Full Text] [Related]
11. Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development. Nian H; Shao H; O'Brien RL; Born WK; Kaplan HJ; Sun D Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5920-7. PubMed ID: 21296823 [TBL] [Abstract][Full Text] [Related]
12. Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells. Cui Y; Shao H; Lan C; Nian H; O'Brien RL; Born WK; Kaplan HJ; Sun D J Immunol; 2009 Jul; 183(1):560-7. PubMed ID: 19542467 [TBL] [Abstract][Full Text] [Related]
13. A shared epitope of the interphotoreceptor retinoid-binding protein recognized by the CD4+ and CD8+ autoreactive T cells. Shao H; Peng Y; Liao T; Wang M; Song M; Kaplan HJ; Sun D J Immunol; 2005 Aug; 175(3):1851-7. PubMed ID: 16034128 [TBL] [Abstract][Full Text] [Related]
14. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. Tarrant TK; Silver PB; Chan CC; Wiggert B; Caspi RR J Immunol; 1998 Jul; 161(1):122-7. PubMed ID: 9647215 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis. Keino H; Watanabe T; Sato Y; Niikura M; Wada Y; Okada AA Arthritis Res Ther; 2008; 10(5):R122. PubMed ID: 18847496 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity. Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291 [TBL] [Abstract][Full Text] [Related]
17. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU). Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639 [TBL] [Abstract][Full Text] [Related]
18. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954 [TBL] [Abstract][Full Text] [Related]
19. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis. Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657 [TBL] [Abstract][Full Text] [Related]
20. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells. Jiang HR; Muckersie E; Robertson M; Forrester JV Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1598-607. PubMed ID: 12657598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]